Compare ACADIA Pharmaceuticals Inc. (ACAD) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs United States Natural Gas Fund — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.45 (market cap $5.07B), while United States Natural Gas Fund trades at $10.19. The key difference: ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.
| ACAD | UNG | |
|---|---|---|
Market Cap | $5.07B | — |
Sector | Health | Commodities - Energy |
52-Week High | $29.41 | $16.90 |
52-Week Low | $20.06 | $9.63 |
Enterprise Value | $4.19B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
UNG trades at $9.74, up 1.14% in the last 24 hours, amid bearish technical signals from moving averages and oscillators. The stock lacks key financial ratio data, but news highlights natural gas futures volatility and comparisons with equity-based ETFs like FCG. Recent articles from WSJ and Reuters (June 2026) note steady trading ranges and record supply-demand forecasts from the EIA, influencing sentiment.
Outlook remains cautious due to technical weakness and commodity price dependence. Risks include geopolitical tensions and weather-driven demand shifts. Opportunities may arise from LNG demand growth, but investors face high volatility without clear fundamental anchors from traditional ratios.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
